comparemela.com

Latest Breaking News On - Acute leukemia clinical research - Page 1 : comparemela.com

Emavusertib Progresses to Phase 2 Study in AML and MDS

The TakeAim Leukemia trial aims to add emavusertib to the treatment paradigm of acute myeloid leukemia and high-risk myelodysplastic syndrome.

United statesDana farber cancer instituteSan diegoErics winerAlices mimsCuris incDivision of hematologyHarvard medical schoolAmerican society of hematology annual meeting expositionLeukemia clinical researchOhio state university comprehensive cancer centerAim leukemiaTakeaim leukemiaAdult leukemiaAcute leukemia clinical researchFindings demonstrate efficacy

Emavusertib Demonstrates Safety, Early Antitumor Activity in Select Patients With FLT3-Mutant R/R AML

Alice Mims, MD, discusses the toxicity profile and initial efficacy of emavusertib in heavily pretreated, FLT3-mutated relapsed/refractory AML.

Alice mimsOhio state university comprehensive cancer centerDivision of hematologyLeukemia clinical researchTakeaim leukemiaAcute leukemia clinical researchFlt3 mutated relapsed refractory amlTakeaim leukemia trial nct04278768Ash annual meeting

vimarsana © 2020. All Rights Reserved.